Dearnaley, D. P., Fossa, S. D., Kaye, S. B., Cullen, M. H., Harland, S. J., Sokal, M. P. J., . . . Stenning, S. P. (2005). Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: A prospective trial (MRC TE17). Nature Publishing Group.
Chicago Style citaatDearnaley, D P., et al. Adjuvant Bleomycin, Vincristine and Cisplatin (BOP) for High-risk Stage I Non-seminomatous Germ Cell Tumours: A Prospective Trial (MRC TE17). Nature Publishing Group, 2005.
MLA citatieDearnaley, D P., et al. Adjuvant Bleomycin, Vincristine and Cisplatin (BOP) for High-risk Stage I Non-seminomatous Germ Cell Tumours: A Prospective Trial (MRC TE17). Nature Publishing Group, 2005.
Let op: Deze citaties zijn niet altijd 100% accuraat.